Trial · NCT03155997
Adverse events848
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
41 to 60 of 848
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Haemorrhoids | Gastrointestinal disorders | 150 mg Abemaciclib + Endocrine Therapy | 68 | 2,791 | 82 |
| other | Haemorrhoids | Gastrointestinal disorders | Endocrine Therapy | 28 | 2,800 | 28 |
| other | Mouth ulceration | Gastrointestinal disorders | 150 mg Abemaciclib + Endocrine Therapy | 39 | 2,791 | 48 |
| other | Mouth ulceration | Gastrointestinal disorders | Endocrine Therapy | 3 | 2,800 | 3 |
| other | Nausea | Gastrointestinal disorders | 150 mg Abemaciclib + Endocrine Therapy | 779 | 2,791 | 1,203 |
| other | Nausea | Gastrointestinal disorders | Endocrine Therapy | 222 | 2,800 | 274 |
| other | Stomatitis | Gastrointestinal disorders | 150 mg Abemaciclib + Endocrine Therapy | 154 | 2,791 | 212 |
| other | Stomatitis | Gastrointestinal disorders | Endocrine Therapy | 30 | 2,800 | 39 |
| other | Toothache | Gastrointestinal disorders | 150 mg Abemaciclib + Endocrine Therapy | 49 | 2,791 | 55 |
| other | Toothache | Gastrointestinal disorders | Endocrine Therapy | 42 | 2,800 | 50 |
| other | Vomiting | Gastrointestinal disorders | 150 mg Abemaciclib + Endocrine Therapy | 454 | 2,791 | 744 |
| other | Vomiting | Gastrointestinal disorders | Endocrine Therapy | 117 | 2,800 | 144 |
| other | Axillary pain | General disorders | 150 mg Abemaciclib + Endocrine Therapy | 28 | 2,791 | 28 |
| other | Axillary pain | General disorders | Endocrine Therapy | 39 | 2,800 | 41 |
| other | Chest pain | General disorders | 150 mg Abemaciclib + Endocrine Therapy | 35 | 2,791 | 40 |
| other | Chest pain | General disorders | Endocrine Therapy | 35 | 2,800 | 36 |
| other | Chills | General disorders | 150 mg Abemaciclib + Endocrine Therapy | 49 | 2,791 | 55 |
| other | Chills | General disorders | Endocrine Therapy | 18 | 2,800 | 18 |
| other | Fatigue | General disorders | 150 mg Abemaciclib + Endocrine Therapy | 1,073 | 2,791 | 1,434 |
| other | Fatigue | General disorders | Endocrine Therapy | 433 | 2,800 | 522 |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03155997/events?page=3